Clinical Trial Update: Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial of chemotherapy for Epstein-Barr Virus-associated lymphomas was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein Barr Virus Associated Hodgkin Lymphoma
• Epstein Barr Virus Associated Non Hodgkin Lymphoma
• Post-transplant Lymphoproliferative Disease

Snippet

Sponsor: University of Miami | Conditions: Epstein Barr Virus Associated Non Hodgkin's Lymphoma, Epstein Barr Virus Associated Hodgkin's Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2019-09-23